TrialEBioMedicine2026

Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial.

Liem T Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.